R3 Stem Cell
R3 Stem Cell is a global leader in regenerative medicine, providing advanced stem cell and exosome therapies through Centers of Excellence in over 45 locations across 7 countries. Their mission is to deliver first-rate, customized regenerative treatments, including stem cells, exosomes, PRP, vitamins, and peptides, to enhance patients' quality of life. With over 26,000 procedures performed and an 85% patient satisfaction rate, they are dedicated to safe, effective, and affordable care. Their therapies are outpatient, nonsteroidal procedures designed to harness the body's natural repair mechanisms and support tissue regeneration, serving patients worldwide, including in Afghanistan, with clinics in Pakistan, Mexico, the Philippines, South Africa, India, Turkey, and the USA.
Industries
Nr. of Employees
small (1-50)
R3 Stem Cell
Scottsdale, Arizona, United States, North America
Products
Perinatal tissue-derived expanded cell preparations
Allogeneic cell therapy preparations derived from perinatal tissues (umbilical cord, Wharton’s jelly, placenta, amniotic fluid/membrane) expanded in culture to provide high live-cell counts for injectable administration.
Amniotic fluid and membrane-derived biologic preparations
Injectable allogeneic products derived from amniotic fluid or amniotic membrane containing cells, growth factors and extracellular vesicles for regenerative use.
Autologous bone marrow- and adipose-derived cell therapies
Autologous treatments using a patient’s own bone marrow or adipose-derived cell concentrates for localized injection therapy.
Exosome and extracellular vesicle preparations
Cell-free extracellular vesicle/enriched exosome preparations intended to deliver signaling molecules and factors that may modulate repair processes.
Platelet-rich plasma (PRP) preparations
Autologous platelet-rich plasma products produced from a patient’s blood and used for tendon, ligament and joint regenerative treatments.
Pre-differentiated and lineage-enriched cell products
Cell therapy preparations pre-differentiated or enriched toward specific tissue phenotypes to target organ-specific repair processes.
Perinatal tissue-derived expanded cell preparations
Allogeneic cell therapy preparations derived from perinatal tissues (umbilical cord, Wharton’s jelly, placenta, amniotic fluid/membrane) expanded in culture to provide high live-cell counts for injectable administration.
Amniotic fluid and membrane-derived biologic preparations
Injectable allogeneic products derived from amniotic fluid or amniotic membrane containing cells, growth factors and extracellular vesicles for regenerative use.
Autologous bone marrow- and adipose-derived cell therapies
Autologous treatments using a patient’s own bone marrow or adipose-derived cell concentrates for localized injection therapy.
Exosome and extracellular vesicle preparations
Cell-free extracellular vesicle/enriched exosome preparations intended to deliver signaling molecules and factors that may modulate repair processes.
Platelet-rich plasma (PRP) preparations
Autologous platelet-rich plasma products produced from a patient’s blood and used for tendon, ligament and joint regenerative treatments.
Pre-differentiated and lineage-enriched cell products
Cell therapy preparations pre-differentiated or enriched toward specific tissue phenotypes to target organ-specific repair processes.
Services
Free clinical consultation
No-cost virtual consultation to assess candidacy for regenerative biologic therapies and provide pre-procedure guidance.
Outpatient regenerative procedure delivery
In-clinic administration of cell-, exosome- and PRP-based therapies via non-surgical routes (intravenous, injection, intrathecal, intranasal/nebulizer) with post-procedure monitoring.
Provider partnership and practice enablement
Program offering clinical onboarding, training, marketing support and operational assistance to clinics integrating standardized regenerative therapy protocols.
Educational webinars and clinician courses
Live webinars for patients and multi-part online courses for clinicians covering regenerative medicine concepts, protocols and patient communication.
Patient concierge and medical travel coordination
Concierge services to assist with travel logistics, escorted ground transportation, lodging arrangements and local navigation for international patients.
Patient financing facilitation
Assistance and referrals to third-party financing options to support payment for procedures when available.
Free clinical consultation
No-cost virtual consultation to assess candidacy for regenerative biologic therapies and provide pre-procedure guidance.
Outpatient regenerative procedure delivery
In-clinic administration of cell-, exosome- and PRP-based therapies via non-surgical routes (intravenous, injection, intrathecal, intranasal/nebulizer) with post-procedure monitoring.
Provider partnership and practice enablement
Program offering clinical onboarding, training, marketing support and operational assistance to clinics integrating standardized regenerative therapy protocols.
Educational webinars and clinician courses
Live webinars for patients and multi-part online courses for clinicians covering regenerative medicine concepts, protocols and patient communication.
Patient concierge and medical travel coordination
Concierge services to assist with travel logistics, escorted ground transportation, lodging arrangements and local navigation for international patients.
Patient financing facilitation
Assistance and referrals to third-party financing options to support payment for procedures when available.
Expertise Areas
- Outpatient administration of regenerative biologics across multiple non-surgical routes
- Cell therapy manufacturing and scale-up (cell culture expansion, 3D culture, bioreactors)
- Processing and enrichment of extracellular vesicle/exosome therapeutics
- Perinatal tissue procurement and donor screening workflows
Key Technologies
- Mesenchymal stem cell preparations from perinatal tissues
- Extracellular vesicle / exosome enrichment and preparation
- Autologous bone marrow- and adipose-derived cell preparation
- Platelet-rich plasma (autologous PRP) processing